Carter Laura 的 Form 4/A 修正申報
修正Gossamer Bio, Inc.（GOSS），2022/10/27 申報
- 申報編號
- 0001728117-22-000094
- 申報時間
- 2022/10/27
- 交易日
- 2022/10/24
- 申報延遲
- 3 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/10/25
這份申報列了 1 筆非衍生性交易。公開市場賣出合計 $5.89 萬。交易後 3 天申報。
這份修正申報取代了 0001728117-22-000090（2022/10/25 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Carter LauraCIK 0001858178 | 高階主管（科學長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/10/24 | Common Stock | S賣出處分 | −4,876 | $12.07F3 | −$58,853.32 | 82,292 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The Reporting Person's purchase of 6,934 shares of common stock at a price of $7.21 per share on July 15, 2022 was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the Reporting Person's sale of common stock reported herein and, to the extent of 2,058 shares, the Reporting Person's sale of common stock at a price of $8.278 per share on March 16, 2022. The Reporting Person has agreed top pay to the Issuer $18,558.51, which, together with the $7,351.42 previously paid to the Issuer on July 15, 2022, represents the full amount of the profit realized in connection with the short-swing transaction.
- F2
Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- F3
This transaction was executed in multiple trades at prices ranging from $11.881 to $12.078 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold.Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 is being amended solely to add new footnote 1 regarding the reporting persons' prior agreement to disgorge short-swing profits to the Issuer.